参考文献/References:
[1] BROOKS R A, FLEMING G F, LASTRA R R, etal. Current recommendations and recent progressin endometrial cancer[J]. CA-A Cancer Journal forClinicians, 2019, 69(4): 258-279.
[2] 高玉霞, 董学彩, 王文翔, 等. 长链非编码RNAHOTTIP 在子宫内膜癌患者组织中的表达及其临床意义[J]. 中国肿瘤生物治疗杂志, 2020, 27(12):1378-1382.GAO Yuxia, DONG Xuecai, WANG Wenxiang, et al.Expression and clinical significance of long non-codingRNA HOTTIP in tissues of patients with endometrialcarcinoma [J]. Chinese Journal of Cancer Biotherapy,2020, 27(12):1378-1382.
[3] 曾庆维．mTOR，HIF-1α 和IL-17 在子宫内膜癌中的表达及临床意义[D]. 河北唐山: 华北理工大学，2018.ZENG Qingwei. The expression of mTOR, HIF-1α and IL-17 in endometrial carcinoma and theirclinical significance [D]. Hebei Tangshan: North ChinaUniversity of Technology, 2018.
[4] RAI R, ESSEL K G, BENBROOK D M, et al.Preclinical efficacy and involvement of AKT, mTOR,and ERK kinases in the mechanism of sulforaphaneagainst endometrial cancer[J]. Cancers, 2020, 12(5):1273.
[5] MOHANKUMAR K, LI Xi, SRIDHARAN S, et al.Nuclear receptor 4A1 (NR4A1) antagonists induceROS-dependent inhibition of mTOR signaling inendometrial cancer[J]. Gynecologic Oncology, 2019,154(1): 218-227.
[6] ZHAO Mengyang, LUO Rongcheng, LIU Yiyi, etal. miR-3188 regulates nasopharyngeal carcinomaproliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR-p-PI3K/AKT-c-JUN[J]. Nature Communications, 2016, 7(1):563-568.
[7] WANG Chunyan, LIU Enqi, LI Wen, et al. MiR-3188inhibits non-small cell lung cancer cell proliferationthrough FOXO1-mediated mTOR-p-PI3K/AKT-c-JUNsignaling pathway[J]. Frontiers in Pharmacology, 2018,9: 1362.
[8] WANG Xiaoning, QIN Xing, YAN Ming, et al. Loss ofexosomal miR-3188 in cancer-associated fibroblasts contributesto HNC progression[J]. Journal of Experimental& Clinical Cancer Research, 2019, 38(1): 151.
[9] XU Mingxi, GU Meng, ZHOU Juan, et al. Interactionof YAP1 and mTOR promotes bladder cancerprogression[J]. International Journal of Oncology,2020, 56(1): 232-242.
[10] MATSUBARA S, MABUCHI S, TAKEDA Y, et al.Prognostic value of pre-treatment systemic immuneinflammationindex in patients with endometrialcancer[J]. PLoS One, 2021, 16(5): e0248871.
[11] 陈丽华, 朱婕曼, 刘玉凤, 等. 子宫内膜癌组织中血管紧张素(1-7) 及线粒体组装受体水平表达与临床病理特征的相关性[J]. 现代检验医学杂志, 2021,36(2):24-27.CHEN Lihua, ZHU Jieman, LIU Yufeng, et al.Correlation between the expression of angiotensin(1-7) and mitochondrial assembled receptors andclinicopathological characteristics in endometrialcancer [J]. Journal of Modern Laboratory Medicine,2021, 36(2):24-27.
[12] JANUSZYK P, JANUSZYK K, WIERZBIKSTRO?SKAM, et al. Analysis of the differences in theexpression of mRNAs and miRNAs associated withdrug resistance in endometrial cancer cells treated withsalinomycin[J]. Current Pharmaceutical Biotechnology,2021, 22(4): 541-548.
[13] CHEN Xiaowen, CHEN Jianli. miR-3188 regulates cellproliferation, apoptosis, and migration in breast cancerby targeting TUSC5 and regulating the p38 MAPKsignaling pathway.[J]. Oncology Research, 2018, 26(3):363-372.
[14] ZHOU Shaojun, DENG Yueling, LIANG Huifang,et al. Hepatitis B virus X protein promotes CREBmediatedactivation of miR-3188 and Notch signalingin hepatocellular carcinoma[J]. Cell Death andDifferentiation, 2017, 24(9): 1577-1587.
[15] 曾庆维, 马思琪, 曲银娥, 等.mTOR, HIF-1a 和IL-17 在子宫内膜癌中表达情况的研究现状[J]. 中国煤炭工业医学杂志, 2017,20(5):617-619.ZENG Qingwei, MA Siqi, QU Yine, et al. Researchstatus of mTOR, HIF-1a and IL-17 expression inendometrial carcinoma[J]. Chinese Journal of CoalIndustry Medicine, 2017,20(5):617-619.
[16] EFSUN A S, CANACANKATAN N, G?RSES ?, etal. Relevance of lipogenesis and AMPK/Akt/mTORsignaling pathway in endometrial cancer[J]. EuropeanReview for Medical and Pharmacological Sciences,2021, 25(2): 687-695.
[17] JING Xuanxuan, PENG Jin, DOU Yu, et al. MacrophageERα promoted invasion of endometrial cancercell by mTOR/KIF5B-mediated epithelial to mesenchymaltransition[J]. Immunology and Cell Biology, 2019,97(6): 563-576.
[18] TORTORELLA L, RESTAINO S, ZANNONI G F, etal. Substantial lymph-vascular space invasion (LVSI)as predictor of distant relapse and poor prognosis inlow-risk early-stage endometrial cancer[J]. Journal ofGynecologic Oncology, 2021, 32(2): e11.
[19] YOKOI E, MABUCHI S, KOMURA N, et al. Incorporationof pretreatment leukocytosis and thrombocytosisinto the FIGO staging system for prognosis in surgicallytreated endometrial cancer[J]. International Journalof Gynaecology and Obstetrics, 2020, 151(2): 272-278.
[20] CHEN Hao, WU Qijun, ZHANG Yunzheng, et al.Nomograms based on the novel platelet index scorepredict postoperative prognosis in endometrial cancer[J].Gynecologic Oncology, 2020, 158(3): 689-697.
相似文献/References:
[1]李 玲a,罗雅文a,何 霞a,等.子宫内膜癌患者BMI与血清HE4,CA125联合检测的诊断价值[J].现代检验医学杂志,2018,33(05):91.[doi:10.3969/j.issn.1671-7414.2018.05.024]
LI Linga,LUO Ya-wena,HE Xiaa,et al.Diagnostic Value of Combined Detection of Body Mass Index and Serum HE4,CA125 in Patients with Endometrial Carcinoma[J].Journal of Modern Laboratory Medicine,2018,33(06):91.[doi:10.3969/j.issn.1671-7414.2018.05.024]
[2]李晓丽,胡陇娟.子宫内膜癌组织中长链非编码RNA ZEB1-AS1的表达与临床特征及对化疗药物耐药性研究[J].现代检验医学杂志,2019,34(04):35.[doi:10.3969/j.issn.1671-7414.2019.04.009]
LI Xiao-li,HU Long-juan.Research on Expression and Clinical Characteristics of
Long-Chain Non-Coding RNA ZEB1-AS1 in Endometrial Carcinoma
and Resistance to Chemotherapy Drugs[J].Journal of Modern Laboratory Medicine,2019,34(06):35.[doi:10.3969/j.issn.1671-7414.2019.04.009]
[3]王娟,刘鑫,席稳燕.HMMR-AS1 在子宫内膜癌化疗耐药中的作用[J].现代检验医学杂志,2020,35(05):45.[doi:10.3969/j.issn.1671-7414.2020.05.012]
WANG Juan,LIU Xin,XI Wen-yan.Effect of HMMR-AS1 on the Chemotherapy-Resistance of
Endometrial Cancer[J].Journal of Modern Laboratory Medicine,2020,35(06):45.[doi:10.3969/j.issn.1671-7414.2020.05.012]
[4]李功娟,张治洋,樊阳阳.FEZF1-AS1在子宫内膜癌中的表达及其与患者临床特征的相关性[J].现代检验医学杂志,2021,36(01):77.[doi:10.3969/j.issn.1671-7414.2021.01.020]
LI Gong-juan,ZHANG Zhi-yang,FAN Yang-yang.Expression of FEZF1-AS1 in Endometrial Carcinoma and Its Correlation with Clinical Characteristics of Patients[J].Journal of Modern Laboratory Medicine,2021,36(06):77.[doi:10.3969/j.issn.1671-7414.2021.01.020]
[5]陈丽华,朱婕曼,刘玉凤,等.子宫内膜癌组织中血管紧张素~1-7及线粒体组装受体水平表达与临床病理特征的相关性[J].现代检验医学杂志,2021,36(02):24.[doi:doi:10.3969/j.issn.1671-7414.2021.02.006]
CHEN Li-hua,ZHU Jie-man,LIU Yu-feng,et al.Correlation between the Expression of Angiotensin (1-7) and Mitochondrial Assembled Receptors and Clinicopathological Characteristics in Endometrial Cancer[J].Journal of Modern Laboratory Medicine,2021,36(06):24.[doi:doi:10.3969/j.issn.1671-7414.2021.02.006]
[6]刘静雅,张海亮,李宝平,等.长链非编码 RNA SNHG1在子宫内膜癌中的表达及调控 PI3K/AKT信号通路的研究[J].现代检验医学杂志,2022,37(01):119.[doi:10.3969/j.issn.1671-7414.2022.01.024]
LIU Jing-ya,ZHANG Hai-liang,LI Bao-ping,et al.Expression of Long Non-coding RNA SNHG1 in Endometrial Carcinoma and Its Regulation of PI3K/AKT Signaling Pathway[J].Journal of Modern Laboratory Medicine,2022,37(06):119.[doi:10.3969/j.issn.1671-7414.2022.01.024]
[7]彭 浩,张印星,谢 环.长链非编码RNA CDKN2BAS 在子宫内膜癌组织表达及其生物学功能研究[J].现代检验医学杂志,2023,38(03):92.[doi:10.3969/j.issn.1671-7414.2023.03.016]
PENG Hao,ZHANG Yin-xing,XIE Huan.Expression and Biological Function of Long Non-coding RNA CDKN2BAS in Endometrial Carcinoma[J].Journal of Modern Laboratory Medicine,2023,38(06):92.[doi:10.3969/j.issn.1671-7414.2023.03.016]
[8]梁燕茹,郑 瑜,李 倩.子宫内膜癌患者术前血清apo AI 和Apelin 水平检测对预测淋巴脉管间隙浸润风险的价值研究[J].现代检验医学杂志,2023,38(05):53.[doi:10.3969/j.issn.1671-7414.2023.05.010]
LIANG Yanru,ZHENG Yu,LI Qian.Value of Preoperative Serum Apo AI and Apelin Levels in Predicting the Risk of Lymph Node Vascular Space Infiltration in Patients with Endometrial Cancer[J].Journal of Modern Laboratory Medicine,2023,38(06):53.[doi:10.3969/j.issn.1671-7414.2023.05.010]
[9]陆 瑞,郭红霞,吴苗苗,等.KIF18B 通过激活Wnt/β catenin 信号通路促进子宫内膜癌细胞增殖和转移的实验研究[J].现代检验医学杂志,2023,38(05):58.[doi:10.3969/j.issn.1671-7414.2023.05.011]
LU Rui,GUO Hongxia,WU Miaomiao,et al.Experimental Study of KIF18B Promoting Endometrial Cancer Cell Proliferation and Metastasis by Activating Wnt/β-catenin Signaling Pathway[J].Journal of Modern Laboratory Medicine,2023,38(06):58.[doi:10.3969/j.issn.1671-7414.2023.05.011]
[10]柴 静,张家弘,李梦雪.子宫内膜癌组织中TMIGD2，TIGIT 的表达及其与临床病理特征的相关性研究[J].现代检验医学杂志,2023,38(06):87.[doi:10.3969/j.issn.1671-7414.2023.06.016]
CHAI Jing,ZHANG Jiahong,LI Mengxue.Expression of TMIGD2 and TIGIT in Endometrial Cancer Tissue and Their Correlation with Clinical Pathological Features[J].Journal of Modern Laboratory Medicine,2023,38(06):87.[doi:10.3969/j.issn.1671-7414.2023.06.016]